- Report
- February 2024
- 173 Pages
Global
From €2379EUR$2,500USD£2,037GBP
- Report
- March 2024
- 195 Pages
Global
From €3210EUR$3,374USD£2,749GBP
€3567EUR$3,749USD£3,054GBP
- Report
- February 2024
- 175 Pages
Global
From €4757EUR$5,000USD£4,073GBP
- Report
- March 2024
- 181 Pages
Global
From €3210EUR$3,374USD£2,749GBP
€3567EUR$3,749USD£3,054GBP
- Report
- May 2024
- 193 Pages
Global
From €5185EUR$5,450USD£4,440GBP
- Report
- February 2024
- 200 Pages
Global
From €4757EUR$5,000USD£4,073GBP
- Report
- February 2024
- 175 Pages
Global
From €4757EUR$5,000USD£4,073GBP
- Report
- February 2024
- 175 Pages
Global
From €4757EUR$5,000USD£4,073GBP
- Report
- November 2023
- 250 Pages
Global
From €4757EUR$5,000USD£4,073GBP
- Report
- November 2023
- 190 Pages
Global
From €4662EUR$4,900USD£3,992GBP
- Clinical Trials
- April 2024
- 450 Pages
Global
From €4757EUR$5,000USD£4,073GBP
- Report
- February 2024
- 111 Pages
Global
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2024
- 115 Pages
Global
From €4519EUR$4,750USD£3,870GBP
- Report
- May 2023
- 202 Pages
Global
From €3425EUR$3,600USD£2,933GBP
- Report
- February 2024
- 79 Pages
Global
From €6655EUR$6,995USD£5,699GBP
- Report
- July 2023
- 332 Pages
United States
From €7607EUR$7,995USD£6,513GBP
- Report
- May 2023
- 65 Pages
North America
From €1427EUR$1,500USD£1,222GBP
- Report
- May 2023
- 75 Pages
Middle East, Africa
From €1427EUR$1,500USD£1,222GBP
- Report
- May 2023
- 76 Pages
Asia Pacific
From €1427EUR$1,500USD£1,222GBP
- Report
- May 2023
- 76 Pages
Europe
From €1427EUR$1,500USD£1,222GBP
Gynecological cancer is a type of cancer that affects the female reproductive system, including the uterus, cervix, ovaries, fallopian tubes, vagina, and vulva. It is the second most common type of cancer among women, and the most common cause of death from gynecological cancer is cervical cancer. Treatment for gynecological cancer typically involves surgery, chemotherapy, and radiation therapy.
Women's health is an important area of focus for gynecological cancer, as it is a major cause of death among women. Early detection and treatment are key to reducing the mortality rate of gynecological cancer, and women should be aware of the signs and symptoms of gynecological cancer. Regular screenings and preventive measures are also important for reducing the risk of developing gynecological cancer.
There are a number of companies in the gynecological cancer market, including Roche, Novartis, AstraZeneca, Merck, and Pfizer. These companies are involved in the development of treatments and therapies for gynecological cancer, as well as in the research and development of new treatments and therapies. Show Less Read more